Related Experiment Video
Updated: Feb 8, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
Published on: July 7, 2014
Statins as Pleiotropic Modifiers of Vascular Oxidative Stress and Inflammation
Costas Psarros1, Evangelos K Economou1, Michael Koutsilieris1
1Department of Experimental Physiology, Medical School, National and Kapodistrian, University of Athens, Athens, Greece.
Insights
Statins combat cardiovascular disease (CVD) by reducing oxidative stress and inflammation, going beyond lipid lowering. Their antioxidant and regulatory effects make them a key intervention for atherosclerosis and overall CVD management.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Cardiovascular disease (CVD) is a primary global cause of death, with atherosclerosis as its main driver.
- Atherosclerosis involves oxidative stress, endothelial dysfunction, and inflammatory responses, including cytokine and adhesion molecule activation.
Purpose of the Study:
- To review the multifaceted role of statins in managing cardiovascular disease.
- To highlight statins' benefits beyond lipid-lowering, focusing on their anti-atherosclerotic mechanisms.
Main Methods:
- Review of clinical trials and pharmacological data on statin efficacy.
- Analysis of statins' effects on oxidative stress, inflammation, and endothelial function.
Main Results:
- Statins exhibit direct antioxidant effects, scavenging free radicals and enhancing antioxidant enzymes.
- Statins modulate the expression of pro-inflammatory and anti-inflammatory cytokines and adhesion molecules.
- These actions collectively combat key processes in atherosclerosis development and progression.
Conclusions:
- Statin therapy offers significant benefits in cardiovascular disease management by addressing underlying atherosclerotic mechanisms.
- Statins are a cornerstone intervention for CVD, with their importance expected to continue.
Abstract:
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the industrialized world and in the future is expected to be the number one killer worldwide. The main cause underlying CVD is atherosclerosis. A key event in atherosclerosis initiation and progression is oxidative stress through the production of reactive oxygen species as well as endothelial dysfunction. Several pro- inflammatory and anti-inflammatory cytokines and proteins are involved in this process, complemented by activation of adhesion molecules that promote leukocyte rolling, tethering and infiltration into the sub-endothelial space. Statins represent the agent of choice since numerous clinical trials have verified that their pharmacological action extends beyond lipid lowering. Statins demonstrate direct anti-oxidant effects by scavenging free radicals and stimulating anti-oxidant enzymes while acting as regulators for cytokine, protein and adhesion molecule expression, all of which are involved in the atherosclerotic process. Statin use is considered one of the most efficient currently used interventions in managing CVD with the likely hood of remaining so in the near future.
More Related Videos
10:02Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
Published on: May 2, 2012
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Related Concept Videos
Inflammation
Oxidation Numbers
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Seedless Vascular Plants
Oxidation-Reduction Reactions